Orthocell Limited (ASX: OCC)
Australia
· Delayed Price · Currency is AUD 1.240
-0.010 (-0.80%)
Dec 20, 2024, 4:10 PM AEST
Orthocell Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Revenue | 5.32 | 5.32 | 4.24 | 1.53 | 1.02 | 0.72 | Upgrade
|
| Revenue Growth (YoY) | 25.27% | 25.27% | 177.01% | 50.47% | 41.48% | -23.91% | Upgrade
|
| Cost of Revenue | 1.63 | 1.63 | 1.03 | 0.7 | 0.63 | 0.51 | Upgrade
|
| Gross Profit | 3.69 | 3.69 | 3.22 | 0.83 | 0.39 | 0.21 | Upgrade
|
| Selling, General & Admin | 6.7 | 6.7 | 5.96 | 5.54 | 4.72 | 4 | Upgrade
|
| Research & Development | 8.67 | 8.67 | 7.6 | 6.82 | 7.34 | 5.47 | Upgrade
|
| Other Operating Expenses | -0.42 | -0.42 | -0.06 | -0 | -0.04 | -0.08 | Upgrade
|
| Operating Expenses | 14.95 | 14.95 | 13.5 | 12.35 | 12.02 | 9.39 | Upgrade
|
| Operating Income | -11.26 | -11.26 | -10.28 | -11.52 | -11.63 | -9.17 | Upgrade
|
| Interest & Investment Income | 1.03 | 1.03 | 0.85 | 0.08 | 0.2 | 0.12 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 0.02 | 0.19 | 0 | - | Upgrade
|
| EBT Excluding Unusual Items | -10.23 | -10.23 | -9.41 | -11.25 | -11.43 | -9.06 | Upgrade
|
| Pretax Income | -10.23 | -10.23 | -9.41 | -11.25 | -11.43 | -9.06 | Upgrade
|
| Income Tax Expense | -3.05 | -3.05 | -3.16 | -2.14 | -2.39 | -2.9 | Upgrade
|
| Net Income | -7.18 | -7.18 | -6.25 | -9.11 | -9.04 | -6.15 | Upgrade
|
| Net Income to Common | -7.18 | -7.18 | -6.25 | -9.11 | -9.04 | -6.15 | Upgrade
|
| Shares Outstanding (Basic) | 202 | 202 | 197 | 195 | 187 | 171 | Upgrade
|
| Shares Outstanding (Diluted) | 202 | 202 | 197 | 195 | 187 | 171 | Upgrade
|
| Shares Change (YoY) | 2.43% | 2.43% | 1.31% | 4.18% | 9.27% | 44.47% | Upgrade
|
| EPS (Basic) | -0.04 | -0.04 | -0.03 | -0.05 | -0.05 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.04 | -0.04 | -0.03 | -0.05 | -0.05 | -0.04 | Upgrade
|
| Free Cash Flow | -7.43 | -7.43 | 13.98 | -6.78 | -4.67 | -5.26 | Upgrade
|
| Free Cash Flow Per Share | -0.04 | -0.04 | 0.07 | -0.03 | -0.02 | -0.03 | Upgrade
|
| Gross Margin | 69.39% | 69.39% | 75.82% | 54.13% | 38.54% | 29.76% | Upgrade
|
| Operating Margin | -211.92% | -211.92% | -242.28% | -752.21% | -1142.59% | -1274.73% | Upgrade
|
| Profit Margin | -135.10% | -135.10% | -147.26% | -594.53% | -887.76% | -854.88% | Upgrade
|
| Free Cash Flow Margin | -139.82% | -139.82% | 329.46% | -442.55% | -458.83% | -731.61% | Upgrade
|
| EBITDA | -10.91 | -10.91 | -9.93 | -11.3 | -11.3 | -8.91 | Upgrade
|
| EBITDA Margin | -205.25% | -205.25% | -233.91% | - | - | - | Upgrade
|
| D&A For EBITDA | 0.35 | 0.35 | 0.35 | 0.22 | 0.34 | 0.26 | Upgrade
|
| EBIT | -11.26 | -11.26 | -10.28 | -11.52 | -11.63 | -9.17 | Upgrade
|
| EBIT Margin | -211.92% | -211.92% | -242.28% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.